Article
An IPI based immune prognostic model for diffuse large B-cell lymphoma
2021-03-04
Abstract excerpt
<h4>Background</h4> International Prognostic Index (IPI) was widely used to better discriminate prognosis of patients with diffuse large B-cell lymphoma (DLBCL). However, there is a significant need to identify novel valuable biomarkers in the context of targeted therapies, such as immune checkpoint blockade (ICB) therapy. <h4>Methods</h4> Gene expression data and clinical information of DLBCL were obtained from...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d06cc889-49b0-5934-96d8-709c681533ae
- DOI
- 10.1101/2021.03.03.433839
